Article
Safety issues in assisted reproduction technology: should ICSI patients have genetic testing before treatment? A practical proposition to help patient information.
Human reproduction (Oxford, England) - 1 Mar 2004
Aittomäki K, Wennerholm U-B, Bergh C, Selbing A, Hazekamp J, Nygren K-G
Abstract excerpt
ICSI is a highly efficient treatment of male factor infertility and therefore increasingly used to treat infertile men successfully. However, when used to treat patients with a genetic cause for their infertility, there may be an increased risk for the offspring. Chromosome aberrations, Y chromosome microdeletions and CFTR (cystic fibrosis transmembrane conductance regulator) mutations alone may explain up to 25%...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
